Literature DB >> 25149304

CTL ELISPOT assay.

Elena Ranieri1, Iulia Popescu, Margherita Gigante.   

Abstract

Enzyme-linked immune absorbent spot (Elispot) is a quantitative method for measuring relevant parameters of T cell activation. The sensitivity of Elispot allows the detection of low-frequency antigen-specific T cells that secrete cytokines and effector molecules, such as granzyme B and perforin. Cytotoxic T cell (CTL) studies have taken advantage with this high-throughput technology by providing insights into quantity and immune kinetics. Accuracy, sensitivity, reproducibility, and robustness of Elispot resulted in a wide range of applications in research as well as in diagnostic field. Actually, CTL monitoring by Elispot is a gold standard for the evaluation of antigen-specific T cell immunity in clinical trials and vaccine candidates where the ability to detect rare antigen-specific T cells is of relevance for immune diagnostic. The most utilized Elispot assay is the interferon-gamma (IFN-γ) test, a marker for CD8(+) CTL activation, but Elispot can also be used to distinguish different subsets of activated T cells by using other cytokines such as T-helper (Th) 1-type cells (characterized by the production of IFN-γ, IL-2, IL-6, IL-12, IL-21, and TNF-α), Th2 (producing cytokines like IL-4, IL-5, IL-10, and IL-13), and Th17 (IL-17) cells. The reliability of Elispot-generated data, by the evaluation of T cell frequency recognizing individual antigen/peptide, is the core of this method currently applied widely to investigate specific immune responses in cancer, infections, allergies, and autoimmune diseases. The Elispot assay is competing with other methods measuring single-cell cytokine production, e.g., intracellular cytokine by FACS or Miltenyi cytokine secretion assay. Other types of lymphocyte frequency and function assays include limiting dilution assay (LDA), cytotoxic T cell assay (CTL), and tetramer staining. Compared with respect to sensitivity the Elispot assay is outranking other methods to define frequency of antigen-specific lymphocytes. The method described herein would like to offer helpful and clear protocols for researchers that apply Elispot. IFN-γ and perforin Elispot assays are described.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25149304     DOI: 10.1007/978-1-4939-1158-5_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  ELISpot Assay for the Detection of ASFV-Specific Interferon-Gamma (IFN-γ)-Producing Cells.

Authors:  Raquel Portugal
Journal:  Methods Mol Biol       Date:  2022

2.  Flt3L and GM-CSF enhance anti-tumor effect of HPV16/18 vaccine via increasing immune response.

Authors:  Yu Liu; Haiyan Zhu; Laiming Mo; Rui Xu; Xiangyun Li; Tian Li; Liang Zhao; Yi Ren; Rongying Ou; Yunsheng Xu
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

3.  IL-10 Has Differential Effects on the Innate and Adaptive Immune Systems of Septic Patients.

Authors:  Monty Mazer; Jaqueline Unsinger; Anne Drewry; Andrew Walton; Dale Osborne; Theresa Blood; Richard Hotchkiss; Kenneth E Remy
Journal:  J Immunol       Date:  2019-09-09       Impact factor: 5.422

4.  Detection of Antigen-specific T cells in Spleens of Vaccinated Mice Applying 3[H]-Thymidine Incorporation Assay and Luminex Multiple Cytokine Analysis Technology.

Authors:  Maria Agallou; Evdokia Karagouni
Journal:  Bio Protoc       Date:  2019-06-05

Review 5.  Comprehensive Review of Human Plasmodium falciparum-Specific CD8+ T Cell Epitopes.

Authors:  Janna Heide; Kerrie C Vaughan; Alessandro Sette; Thomas Jacobs; Julian Schulze Zur Wiesch
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

6.  Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series.

Authors:  Ryota Tamura; Yukina Morimoto; Kenzo Kosugi; Mizuto Sato; Yumiko Oishi; Ryo Ueda; Ryogo Kikuchi; Hideaki Nagashima; Tetsuro Hikichi; Shinobu Noji; Yutaka Kawakami; Hikaru Sasaki; Kazunari Yoshida; Masahiro Toda
Journal:  BMC Cancer       Date:  2020-03-12       Impact factor: 4.430

7.  Hepatitis E Infection in a Longitudinal Cohort of Hepatitis C Virus and HCV/HIV Coinfected Persons.

Authors:  Kenneth E Sherman; Shyam Kottilil; Susan D Rouster; Enass A Abdel-Hameed; Ceejay L Boyce; Heidi L Meeds; Norah Terrault; M Tarek Shata
Journal:  AIDS Res Hum Retroviruses       Date:  2021-05-10       Impact factor: 1.723

8.  Medical Treatment of Lung Cancer: Can Immune Cells Predict the Response? A Systematic Review.

Authors:  Philippe Rochigneux; Alejandro J Garcia; Brice Chanez; Anne Madroszyk; Daniel Olive; Edward B Garon
Journal:  Front Immunol       Date:  2020-06-24       Impact factor: 7.561

Review 9.  Methods for Measuring T-Cell Memory to Vaccination: From Mouse to Man.

Authors:  Amy Flaxman; Katie J Ewer
Journal:  Vaccines (Basel)       Date:  2018-07-21

10.  FLT3L and granulocyte macrophage colony-stimulating factor enhance the anti-tumor and immune effects of an HPV16 E6/E7 vaccine.

Authors:  Zhenzhen Ding; Hua Zhu; Laiming Mo; Xiangyun Li; Rui Xu; Tian Li; Liang Zhao; Yi Ren; Yunsheng Xu; Rongying Ou
Journal:  Aging (Albany NY)       Date:  2019-12-24       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.